跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
BIVALIRUDIN FOR INJECTION
Authorized
STANDARD
BIVALIRUDIN FOR INJECTION
fresenius kabi canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
7b7288af98f46462
Company
fresenius kabi canada ltd
Type
Standard
Approval Details
Approval Id
7b7288af98f46462
Drug Approval Canada Name
BIVALIRUDIN FOR INJECTION
Product Name
BIVALIRUDIN FOR INJECTION
Status
Marketed
Status Date
2019-04-23
Original Market Date
2019-04-23
Din
02435268
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
20:12.04.12
Atc Original
B01AE06 BIVALIRUDIN
Atc Name
b 01 ae 06
Aig Number
0148342001
Company Name
fresenius kabi canada ltd
Company Address
165 Galaxy Blvd, Suite 100, Toronto, Ontario, Canada, M9W 0C8
Active Ingredients
BIVALIRUDIN
250 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
7b7288af98f46462
Type
Standard
Back to Health Canada Approvals
BIVALIRUDIN FOR INJECTION - Health Canada Drug Approval Details